chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Hypoaesthesia, Joint swelling, Lymphadenopathy, Pain
Clinical narrative: fever of 38.3 Celsius; almost tennis ball size swelling of right under armpit; tingling and numbness in fingers/hand/some numbness right finger; tingling and numbness in fingers/hand; swelling of wrist; Chills; sweat; fatigue; no energy; Swollen upper arm, very painful; Swollen upper arm, very painful; pain also in former injection site for first dose; whole body sore; chest tightness; swelling left lymph node under armpit; tenderness of lymph node at right collar bone; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EW0182) via an unspecified route of administration in right arm on 14May2021 11:00 AM (age at vaccination 53-year-old) as dose 2 single, for COVID-19 immunisation at Pharmacy or Drug Store. The patient medical history included exercise and allergy induced asthma (mild). Patient was not pregnant at time of vaccination. Known allergies were none. No other vaccine in four weeks. The patient's concomitant medications in two weeks were none. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0161) on left arm on 23Apr2021 11:00 (age at 53-year-old) as dose 1 single for COVID-19 Immunization and 10 min after injection, patient experienced tingling in left hand/fingers, dizziness, and slight swelling of left wrist. Dizziness gone after 30 min. Chills and sweat (no measurable fever) during the night, general fatigue and ill feeling one day after vaccine. Swollen, painful lymph node under left arm (lasting about 2 weeks). It was reported that 5 min after injection on 14May2021 11:05 AM patient had tingling and numbness in fingers/hand, swelling of wrist. Chills and sweats (no fever), lasting through the night. Swollen upper arm, very painful, pain also in former injection site of first dose, whole body sore. Some chest tightness. Next morning body/arm soreness significantly better, still chills and sweats (no fever), almost tennis ball size swelling of right under armpit and tenderness of lymph node at right collar bone as well as slight swelling left lymph node under armpit. Fatigue, no energy, some numbness right finger. 29 h after injection on 15May2021 16:00, fever of 38.3 Celsius, lasting through the night. No treatment received for adverse events. No covid prior vaccination. No covid tested post vaccination. The outcome of all events was unknown.  No follow-up attempts possible. No further information expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia, Peripheral swelling, Pyrexia, Swelling
Clinical narrative: fever of 38.3 Celsius; almost tennis ball size swelling of right under armpit; tingling and numbness in fingers/hand/some numbness right finger; tingling and numbness in fingers/hand; swelling of wrist; Chills; sweat; fatigue; no energy; Swollen upper arm, very painful; Swollen upper arm, very painful; pain also in former injection site for first dose; whole body sore; chest tightness; swelling left lymph node under armpit; tenderness of lymph node at right collar bone; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EW0182) via an unspecified route of administration in right arm on 14May2021 11:00 AM (age at vaccination 53-year-old) as dose 2 single, for COVID-19 immunisation at Pharmacy or Drug Store. The patient medical history included exercise and allergy induced asthma (mild). Patient was not pregnant at time of vaccination. Known allergies were none. No other vaccine in four weeks. The patient's concomitant medications in two weeks were none. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0161) on left arm on 23Apr2021 11:00 (age at 53-year-old) as dose 1 single for COVID-19 Immunization and 10 min after injection, patient experienced tingling in left hand/fingers, dizziness, and slight swelling of left wrist. Dizziness gone after 30 min. Chills and sweat (no measurable fever) during the night, general fatigue and ill feeling one day after vaccine. Swollen, painful lymph node under left arm (lasting about 2 weeks). It was reported that 5 min after injection on 14May2021 11:05 AM patient had tingling and numbness in fingers/hand, swelling of wrist. Chills and sweats (no fever), lasting through the night. Swollen upper arm, very painful, pain also in former injection site of first dose, whole body sore. Some chest tightness. Next morning body/arm soreness significantly better, still chills and sweats (no fever), almost tennis ball size swelling of right under armpit and tenderness of lymph node at right collar bone as well as slight swelling left lymph node under armpit. Fatigue, no energy, some numbness right finger. 29 h after injection on 15May2021 16:00, fever of 38.3 Celsius, lasting through the night. No treatment received for adverse events. No covid prior vaccination. No covid tested post vaccination. The outcome of all events was unknown.  No follow-up attempts possible. No further information expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness, Vaccination site pain
Clinical narrative: fever of 38.3 Celsius; almost tennis ball size swelling of right under armpit; tingling and numbness in fingers/hand/some numbness right finger; tingling and numbness in fingers/hand; swelling of wrist; Chills; sweat; fatigue; no energy; Swollen upper arm, very painful; Swollen upper arm, very painful; pain also in former injection site for first dose; whole body sore; chest tightness; swelling left lymph node under armpit; tenderness of lymph node at right collar bone; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EW0182) via an unspecified route of administration in right arm on 14May2021 11:00 AM (age at vaccination 53-year-old) as dose 2 single, for COVID-19 immunisation at Pharmacy or Drug Store. The patient medical history included exercise and allergy induced asthma (mild). Patient was not pregnant at time of vaccination. Known allergies were none. No other vaccine in four weeks. The patient's concomitant medications in two weeks were none. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0161) on left arm on 23Apr2021 11:00 (age at 53-year-old) as dose 1 single for COVID-19 Immunization and 10 min after injection, patient experienced tingling in left hand/fingers, dizziness, and slight swelling of left wrist. Dizziness gone after 30 min. Chills and sweat (no measurable fever) during the night, general fatigue and ill feeling one day after vaccine. Swollen, painful lymph node under left arm (lasting about 2 weeks). It was reported that 5 min after injection on 14May2021 11:05 AM patient had tingling and numbness in fingers/hand, swelling of wrist. Chills and sweats (no fever), lasting through the night. Swollen upper arm, very painful, pain also in former injection site of first dose, whole body sore. Some chest tightness. Next morning body/arm soreness significantly better, still chills and sweats (no fever), almost tennis ball size swelling of right under armpit and tenderness of lymph node at right collar bone as well as slight swelling left lymph node under armpit. Fatigue, no energy, some numbness right finger. 29 h after injection on 15May2021 16:00, fever of 38.3 Celsius, lasting through the night. No treatment received for adverse events. No covid prior vaccination. No covid tested post vaccination. The outcome of all events was unknown.  No follow-up attempts possible. No further information expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Vaccination site pain
Clinical narrative: Injection site pain; Sore arm for 2 plus days; Tiredness for 3 days; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient experienced injection site pain, sore arm for 2 plus days and tiredness for 3 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events injection site pain, sore arm for 2 plus days and tiredness for 3 days was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Lymphadenopathy, Oropharyngeal pain, Pain
Clinical narrative: Sharp pains in right temple area/ right side and shooting pain radiating from jaw area to ear to right temple; Over several days I have developed a sore throat on right side and shooting pain radiating from jaw area to ear to right temple; I have swollen lymph nodes; Severe fatigue; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CW0167) via an unspecified route of administration in the Left arm on 24Apr2021 at 11:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to penicillin. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8737) via an unspecified route of administration in the right arm on 27Mar2021 (at the age of 55 -years-old) as a single dose for COVID-19 immunisation.  On 13May2021 the patient experienced sharp pains in right temple area. Over several days she had developed a sore throat on right side and shooting pain radiating from jaw area to ear to right temple. She had swollen lymph nodes, severe fatigue, and brain fog. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events sharp pains in right temple area. Over several days she had developed a sore throat on right side and shooting pain radiating from jaw area to ear to right temple. She had swollen lymph nodes, severe fatigue, and brain fog were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Oropharyngeal pain, Vaccination site pain
Clinical narrative: Mild sore throat; Arm pain at injection site; Muscle soreness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15May2021 at 12:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Apr2021 at 13:15 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15May2021, the patient experienced mild sore throat, arm pain at injection site, muscle soreness and fatigue. It was reported that the events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events mild sore throat, arm pain at injection site, muscle soreness and fatigue were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Pyrexia
Clinical narrative: Sweats; Chills; Fever; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 12May2021 at 13:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, COVID-19 infection. The patient had known allergies to penicillin (MANUFACTURER UNKNOWN), sulfa (sulfonamide) and cefaclor (CECLOR). The concomitant medication included cannabis sativa (CANNABIS) for an unknown indication, from unspecified date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12May2021 at 18:00, the patient experienced chills, sweats, fever, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were not taken as a result of reported events. The clinical outcome of the events chills, sweats, fever, headache and fatigue resolved with sequelae on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, SARS-CoV-2 test
Clinical narrative: I had a metallic taste in my mouth for about 5 days after the second dose of Pfizer vaccine. More specifically towards the back of my throat; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 07May2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included lyme disease since unknown date. The patient had no known allergies. Concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 16Apr2021 at 09:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08May2021 the patient felt metallic taste in mouth for about 5 days more specifically towards the back of throat. This did not affect taste, and it did not involve the tongue or gums. It seems to have started wearing off after 5 days or so. On 10May2021, the patient underwent COVID-19 virus test (Curative) and the results was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event.  The clinical outcome of the event metallic taste in mouth for about 5 days more specifically towards the back of throat was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Hot flush, Lymphadenopathy
Clinical narrative: Hot flashes; Body aches; Low energy; Chills; Headache; Lymph node swelling on armpit, neck, and elbow; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 13May2021 as a single dose for COVID-19 immunisation. Medical history included no health issues. The patient had no known allergies. The patient received unspecified medication for birth control within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 22Apr2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced chills, hot flashes, headache, body aches, low energy and lymph node swelling on armpit, neck, and elbow at the same side of the shot. It was unknown whether therapeutic measure was taken as a result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, hot flashes, headache, body aches, low energy, lymph node swelling on armpit, neck and elbow was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Hot flashes; Body aches; Low energy; Chills; Headache; Lymph node swelling on armpit, neck, and elbow; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 13May2021 as a single dose for COVID-19 immunisation. Medical history included no health issues. The patient had no known allergies. The patient received unspecified medication for birth control within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 22Apr2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced chills, hot flashes, headache, body aches, low energy and lymph node swelling on armpit, neck, and elbow at the same side of the shot. It was unknown whether therapeutic measure was taken as a result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, hot flashes, headache, body aches, low energy, lymph node swelling on armpit, neck and elbow was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Ocular hyperaemia, Pruritus, Rash
Clinical narrative: acute pruritic hands.; scalp and upper body was quite itchy; face red; eyes bloodshot; measles like bumps on back and back of my upper arms.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733), via an unspecified route of administration in the left arm on 13May2021 at 19:30 (at the age of 58-year-old), as a single dose for COVID-19 immunisation. Medical history included rash on left hand for well over a year and had been through 3 dermatologists (no help at all) and also reported that the patient had no known allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158), via an unspecified route of administration in the left arm on 16Apr2021 at 16:30 (at the age of 58-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 01:00, after approximately 36hrs after injection the patient woke up mid-sleep and experienced acute pruritic hands quite severe sensation, after a few minutes with my hands under cold running water the patient`s scalp and upper body was quite itchy, face red, eyes bloodshot, measles like bumps on back and back of upper arms. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events  of acute pruritic hands quite severe sensation, scalp and upper body was quite itchy, face red, eyes bloodshot, measles like bumps on back and back of upper arms were recovered in May2021.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Eye discharge, Vision blurred
Clinical narrative: Blurry vision; Morning discharge from the eyes,; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172), via an unspecified route of administration in the left arm on 04May2021 at 09:30 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetes. The patient did not have any allergies to medications, food, or other products. Concomitant medications included unspecified medication for diabetes. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07May2021 at 08:00, the patient experienced blurry vision, morning discharge from the eyes and dizziness. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events blurry vision, morning discharge from the eyes and dizziness were not resolved at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Cough, Diarrhoea, Fatigue
Clinical narrative: Scratchy throat; Cough; Body aches; Fever; Chills; Headache; extreme tiredness; Stomach pain; Multiple loose stool bowel movements; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old unknown gender patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the arm left on 14May2021 at 12:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included pantoprazole sodium sesquihydrate (PROTONIX), ubidecarenone (CO Q-10), rosuvastatin calcium (CRESTOR), progesterone (MANUFACTURER UNKNOWN) and estradiol (ESTRACE); all from unknown date for unknown indication. The patient previously took whey protein on unknown date and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 11:00 the patient experienced congestion, scratchy throat, cough, body aches, fever, chills, headache, extreme tiredness, stomach pain, multiple loose stool bowel movements. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events congestion, scratchy throat, cough, body aches, fever, chills, headache, extreme tiredness, stomach pain, multiple loose stool bowel movements were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia, Throat irritation
Clinical narrative: Scratchy throat; Cough; Body aches; Fever; Chills; Headache; extreme tiredness; Stomach pain; Multiple loose stool bowel movements; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old unknown gender patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the arm left on 14May2021 at 12:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included pantoprazole sodium sesquihydrate (PROTONIX), ubidecarenone (CO Q-10), rosuvastatin calcium (CRESTOR), progesterone (MANUFACTURER UNKNOWN) and estradiol (ESTRACE); all from unknown date for unknown indication. The patient previously took whey protein on unknown date and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 11:00 the patient experienced congestion, scratchy throat, cough, body aches, fever, chills, headache, extreme tiredness, stomach pain, multiple loose stool bowel movements. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events congestion, scratchy throat, cough, body aches, fever, chills, headache, extreme tiredness, stomach pain, multiple loose stool bowel movements were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site urticaria
Clinical narrative: Immediate rash/welts about 2 inches above and 1 inch below and around the injection site; Immediate rash/welts about 2 inches above and 1 inch below and around the injection site; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 16May2021 at 09:15 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history included lactose intolerance. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), fiber pills, and probiotic taken for unknown indications and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 09:15, the patient experienced immediate rash/welts about 2 inches above and 1 inch below and around the injection site. It happened within seconds of receiving the vaccine and was gone about 30 minutes later. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcomes of the event immediate rash/welts about 2 inches above and 1 inch below and around the injection site was recovered on 16May2021 at 09:45.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discharge, Vaccination site swelling
Clinical narrative: Arm swelled at injection site; Injection site appeared to leak fluid; This is a spontaneous report from a contactable consumer. A 31-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm on 11May2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11May2021, the patient experienced arm swelled at injection site and appeared to leak fluid. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events arm swelled at injection site and appeared to leak fluid recovered on an unspecified date in May2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Hyperhidrosis, Pain in extremity, Pyrexia
Clinical narrative: Rash; Sweating; Vomiting; high fever; arm is still hurting her; Dizziness; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 53-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot number: EW0171) via an unspecified route of administration, administered in right arm on 22Apr2021 13:55 as single dose for covid-19 immunisation. The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot number: EW0176) via an unspecified route of administration, administered in her left arm on 13May2021 15:00 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 23Apr2021, the patient experienced dizziness and the day after she got the first shot was when her arm started killing her and also stated it has improved but if she pushes on her arm it still hurts. On 24Apr2021, patient experienced vomiting and high fever. On 26Apr2021, patient experienced sweating and on 28Apr2021 patient developed rash. Patient confirmed that confirmed that the symptoms started after she received the COVID 19 vaccine. The patient underwent lab test which included body temperature: 101 Fahrenheit. Therapeutic measures were taken as a result of events dizziness, rash, sweating, vomiting, high fever, arm is still hurting her. Treatment drugs included Mucinex and Tylenol. Patient stated sweating stopped last week around 01May2021 but then she got her second shot and it started back up again and is still going on. The outcome of the event dizziness, sweating and rash was not recovered and the outcome of the event high fever and vomiting was recovered on 30Apr2021 and the outcome of the event arm is still hurting her was recovering.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vomiting
Clinical narrative: Rash; Sweating; Vomiting; high fever; arm is still hurting her; Dizziness; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 53-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot number: EW0171) via an unspecified route of administration, administered in right arm on 22Apr2021 13:55 as single dose for covid-19 immunisation. The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot number: EW0176) via an unspecified route of administration, administered in her left arm on 13May2021 15:00 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 23Apr2021, the patient experienced dizziness and the day after she got the first shot was when her arm started killing her and also stated it has improved but if she pushes on her arm it still hurts. On 24Apr2021, patient experienced vomiting and high fever. On 26Apr2021, patient experienced sweating and on 28Apr2021 patient developed rash. Patient confirmed that confirmed that the symptoms started after she received the COVID 19 vaccine. The patient underwent lab test which included body temperature: 101 Fahrenheit. Therapeutic measures were taken as a result of events dizziness, rash, sweating, vomiting, high fever, arm is still hurting her. Treatment drugs included Mucinex and Tylenol. Patient stated sweating stopped last week around 01May2021 but then she got her second shot and it started back up again and is still going on. The outcome of the event dizziness, sweating and rash was not recovered and the outcome of the event high fever and vomiting was recovered on 30Apr2021 and the outcome of the event arm is still hurting her was recovering.  Follow-up attempts are completed. No further information is expected.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash appeared 24 hours after injection; This is a spontaneous report from a non-contactable consumer, the patient. A 12-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GW0182) via an unspecified route of administration in the left arm on 14May2021 at 18:00 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medications, food, or other products. The patient did not take any other medications within two weeks prior to vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021, rash appeared 24 hours after injection. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of rash and included treatment with Benadryl. The clinical outcome of the event rash appeared 24 hours after injection was resolved on an unknown date in May2021.   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Neck pain
Clinical narrative: My face went numb 30min after injection.; Then I got pain in my head; Then I got pain in my head and neck; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 05May2021 at 13:00 (at the age of 28-year-old) as a single dose of COVID-19 immunisation. Medical history included ehlers-danlos syndrome, postural orthostatic tachycardia syndrome and hashimoto's thyroiditis. The patient had no known allergies to food, medications or other products. The patient previously took paracetamol (TYLENOL) from unknown dates for relieving pain within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 13:30 thirty minutes after injection, the patient experienced numbness in face, then she got pain in her head and neck similar to whiplash. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measure was taken as a result of the reported event numbness in face. Therapeutic measures were taken as a result of the reported events pain in head and neck which included treatment with motrin and tylenol from an unknown dates. The clinical outcome of the events numbness in face, pain in head and neck lasted for 10 days and recovered with sequelae on 15May2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Menstruation irregular, Nausea, Pyrexia
Clinical narrative: Having low grade fever, nausea, headache and fatigue; Having low grade fever, nausea, headache and fatigue; Having low grade fever, nausea, headache and fatigue; Having low grade fever, nausea, headache and fatigue; She got her period within 12 hours of getting the vaccine which was 2 weeks early; This is a spontaneous report from a contactable consumer or other non hcp. A 46-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EW0176; Expiration Date: 01May2021) via an unspecified route of administration, in Arm Left on 01May2021 15:50 (age at vaccination 46years old) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had historical vaccine of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number was not reported) via an unspecified route of administration, on unspecified date as single dose for covid-19 immunisation. The patient experienced having low grade fever, nausea, fatigue on 02May2021 and headache, she got her period within 12 hours of getting the vaccine which was 2 weeks early on 01May2021. Clinical course was reported as I received my 2nd dose on 01May2021, aside from having low grade fever, nausea, headache, and fatigue that was more than usual, I also got my period within 12 hours of getting the vaccine, which was 2 weeks early. I know it's not as common. The patient received treatment for headache with Tylenol. The clinical outcome of the event was recovered in 02May2021 and another event was recovered in May2021. Therapeutic measures were taken as a result of having low grade fever, nausea, headache and fatigue.  No follow-up attempts are possible. No further information expected.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Swollen bottom lip; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 15May2021 at 10:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and outside allergies. No concomitant medications were reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16May2021 at 22:00, the patient experienced swollen bottom lip. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event swollen bottom lip was recovered on an unknown date in May2021.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chest pain, Cyst, Hepatic enzyme increased, Thyroid function test abnormal
Clinical narrative: Elevated liver enzymes; liver cysts; Abnormal Thyroid lab values; chest pain; abdominal pain; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6207) via an unspecified route of administration in the left arm on 17Mar2021 at 16:00 and the second dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the left arm on 20Apr2021 at 16:00  (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer in 2015. The patient previously took sumatriptan (IMITREX) for unknown indication and from unknown date and experienced allergy. Concomitant medications included pravastatin sodium (PRAVASTATINE),  colecalciferol (VITAMIN D) and ibuprofen (MOTRIN) ; all from an unknown date, for an unknown indication, unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021, at 04:00 the patient experienced elevated liver enzymes, liver cysts, abnormal thyroid lab values, chest and abdominal pain. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the events which included treatment with medications (not specified). The clinical outcome of the events of elevated liver enzymes, liver cysts, abnormal thyroid lab values, chest and abdominal pain were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Malaise, Pyrexia
Clinical narrative: Joint Pain; Chills; Fever; Tiredness; Feeling Unwell; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration on 16May2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications taken within two weeks of vaccination were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Other vaccines within four weeks prior to the vaccination was not reported. On 16May2021, the patient experienced joint pain, chills, fever, tiredness, feeling unwell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events joint pain, chills, fever, tiredness, feeling unwell was not resolved at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: muscle aches/ severe muscle aches; fever; chills; worse fatigue/ exhaustion/ tired; mostly slept; sore arm; This is a spontaneous report from a contactable other healthcare professional (patient). A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), intramuscular, administered in the right deltoid on 21Jan2021, at 10:00 (Batch/Lot Number: EL9261, Expiration Date: May2021, at the age of 49 years old) as dose 2, single for COVID-19 immunisation. Since early Apr2020, the patient spent 4-6 hours/day face-to-face with COVID patients for months. After starting work on COVID unit, she previously had mild illness, sore throat, fatigue, achey, but no cough, and fever not over 99 from 09Apr2020 to 17Apr2021. Unknown if she had COVID. She kept working in the COVID unit per requirements at that time. On 29Dec2020, she had COVID antibody test: negative. The patient's concomitant medications were not reported. She did not have prior vaccinations. The patient previously received first dose of BNT162B2 (Batch/Lot Number: EJ1685, Expiration Date: Mar2021), intramuscular, administered in the right deltoid on 31Dec2020 (at the age of 49 years old) for COVID-19 immunisation. On 21Jan2021, at 14:00, the patient experienced muscle aches (also reported as severe muscle aches), fever for 3-4 days, chills, worse fatigue/exhaustion, mostly slept for 2-3 days, sore arm, and tired- 1 week. No therapeutic measures were taken as a result of the events and the patient just rested. The patient recovered from the events on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: muscle aches/ severe muscle aches; fever; chills; worse fatigue/ exhaustion/ tired; mostly slept; sore arm; This is a spontaneous report from a contactable other healthcare professional (patient). A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), intramuscular, administered in the right deltoid on 21Jan2021, at 10:00 (Batch/Lot Number: EL9261, Expiration Date: May2021, at the age of 49 years old) as dose 2, single for COVID-19 immunisation. Since early Apr2020, the patient spent 4-6 hours/day face-to-face with COVID patients for months. After starting work on COVID unit, she previously had mild illness, sore throat, fatigue, achey, but no cough, and fever not over 99 from 09Apr2020 to 17Apr2021. Unknown if she had COVID. She kept working in the COVID unit per requirements at that time. On 29Dec2020, she had COVID antibody test: negative. The patient's concomitant medications were not reported. She did not have prior vaccinations. The patient previously received first dose of BNT162B2 (Batch/Lot Number: EJ1685, Expiration Date: Mar2021), intramuscular, administered in the right deltoid on 31Dec2020 (at the age of 49 years old) for COVID-19 immunisation. On 21Jan2021, at 14:00, the patient experienced muscle aches (also reported as severe muscle aches), fever for 3-4 days, chills, worse fatigue/exhaustion, mostly slept for 2-3 days, sore arm, and tired- 1 week. No therapeutic measures were taken as a result of the events and the patient just rested. The patient recovered from the events on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.